Welcome to LookChem.com Sign In|Join Free

CAS

  • or

915369-04-9

Post Buying Request

915369-04-9 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

915369-04-9 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 915369-04-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,1,5,3,6 and 9 respectively; the second part has 2 digits, 0 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 915369-04:
(8*9)+(7*1)+(6*5)+(5*3)+(4*6)+(3*9)+(2*0)+(1*4)=179
179 % 10 = 9
So 915369-04-9 is a valid CAS Registry Number.

915369-04-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name 6-bromo-4-(3-chloro-4-fluoroanilino)quinoline-3-carbonitrile

1.2 Other means of identification

Product number -
Other names 3-Quinolinecarbonitrile,6-bromo-4-[(3-chloro-4-fluorophenyl)amino]

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:915369-04-9 SDS

915369-04-9Relevant articles and documents

Synthesis and photophysical properties of a fluorescent cyanoquinoline probe for profiling ERBB2 kinase inhibitor response

Lee, Heajin,Landgraf, Ralf,Wilson, James N.

, p. 6016 - 6023 (2017)

A fluorescent probe targeting the ERBB2 receptor tyrosine was designed, synthesized and evaluated as reporter of ERBB2 dynamics in overexpressing BT474, i.e. Her2(+), cells. Two cyanoquinazoline (CQ) probes modeled after type-I (CQ1) or active state and t

SMALL MOLECULE INHIBITORS OF EGFR AND PI3K

-

Page/Page column 94, (2016/07/05)

This invention is in the field of medicinal chemistry. In particular, the invention relates to a new class of small-molecules having a quinazoline structure or a quinoline structure which function as dual inhibitors of EGFR proteins and PI3K proteins, and their use as therapeutics for the treatment of cancer and other diseases.

3-Cyanoquinoline inhibitors of Tpl2 kinase and methods of making and using the same

-

Page/Page column 9, (2008/06/13)

The present invention provides compounds of formula (I): and pharmaceutically acceptable salts thereof, wherein R1, R2, R3, R4, R5, R6, R7, R8, m and n are defined as

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 915369-04-9